In an in vivo osteonecrosis model, rabbits treated with depomedrol plus ACTH for 1 month demonstrated fewer signs of trabecular necrosis and increased expression of VEGF in comparison to groups treated with the steroid depomedrol alone [9]. The gene discussed is VEGFA; the disease is osteonecrosis.